Ganot Capital has extended a funding round to Notal Vision to $25 million to support the growth of the company’s ForeseeHome AMD monitoring program, according to a press release.
“Pursuing additional funding has allowed us to expand our ForeseeHome field-based sales team,” Kester Nahen, PhD, Notal Vision CEO, said in the release. “We have a proven model that includes low-cost medical devices, an effective artificial intelligence-driven decision support solution and a dependable clinical patient engagement platform. With the additional investment, we believe we will be
Uncategorized